Review reveals improved pharmacokinetic properties in drug constructs using co-crystal polymorphs, suggesting new formulation strategies.
Co-crystals offer a promising strategy to create drug constructs for which the pharmacokinetic properties of an active pharmaceutical ingredient can be improved without compromising its pharmacological effectiveness. The integration of...
No takes yet. Share an insight, caveat, or question.
Liang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: